Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study
Lee E, Burgess K. Alternative Therapies in Health and Medicine 2025;31:20-24.
What it found
No adverse effects were reported in either participant.
Limitations
Two healthy adults, no control group. It cannot show long-term safety or any benefit.
Research and education only. Not medical advice. Many peptides on this site are not approved by the FDA for human use. Doses shown are the ones used in published studies and are not a recommendation. Talk to a licensed clinician before using any of them. Read the full disclaimer.